JESUS PEREIRA: Open Payments
NPI 1881726032 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 59 payments from 15 companies in 2025. Trend: 2023 $1,175 · 2024 $1,347 · 2025 $1,106
Food & beverage: $1,007Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $370 |
| E.R. Squibb & Sons, L.L.C. | 7 | $138 |
| GENZYME CORPORATION | 3 | $105 |
| Organon LLC | 6 | $93 |
| ABBVIE INC. | 3 | $68 |
| ANI Pharmaceuticals, Inc. | 2 | $49 |
| Incyte Corporation | 2 | $49 |
| UCB, Inc. | 2 | $48 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
Products named: TREMFYA, Sotyktu, DUPIXENT, SKYRIZI, VTAMA, Oxistat, OPZELURA, Bimzelx.
Industry payments across FL — which companies pay providers there.
